Biogen Inc. (BIIB) Biogen and Sage Zuranolone Webcast (Transcript)

Biogen Inc. (NASDAQ:BIIB) Biogen and Sage Zuranolone Webcast December 6, 2022 8:00 AM ET Company Participants Helen Rubinstein - Director, Investor Relations, Sage Therapeutics Chris Benecchi - Chief Business Officer, Sage Therapeutics Maha Radhakrishnan - Group SVP and Chief Medical Officer, Biogen Greg Mattingly - Associate Clinical Professor, Washington University Alisha Alaimo - President of U.S. Organization, Biogen Mike Hencke - Head, Investor Relations, Biogen Jim Doherty - Chief Development Officer, ...